Purchase Order 75N93020P01273

The National Institute of Allergy and Infectious Diseases issued a purchase order to Life Technologies Corporation on September 10, 2021, with a ceiling value of $66,556.28 to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability. The order is firm fixed price with no set-aside. Place of performance is Carlsbad, California. The ultimate completion date is July 30, 2022. The...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $46,200.00 on June 25, 2019, with completion scheduled for June 27, 2020. The order covers biologicals for delivery to Carlsbad, California. The underlying solicitation was posted June 3, 2019 with a due date of June 17, 2019. Pricing is firm fixed price.</p>

This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lakepharma, Inc. for $21,769.00 in testing services. The contract has no set-aside designation and was completed on July 3, 2015. Lakepharma, Inc. is a Contract Development and Manufacturing Organization (CDMO) that provides pharmaceutical and biotech services, including affinity maturation, production of...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation valued at $49,500 on August 15, 2017, with completion by September 14, 2017. Performance occurs in Carlsbad, California. The order is firm fixed price with no small business set-aside. The specific requirements and line items are not detailed in the source documentation.</p>

<p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Geneuniversity Inc. for custom DNA services on August 7, 2020, with a ceiling value of $10,435.00 and firm fixed-price terms. The order was issued under quote no. 1007569 (LAW2034981) with an ultimate completion date of September 5, 2020. Performance occurs at the awardee's facility in Newark, Delaware.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $19,760.00 on June 21, 2019, with ultimate completion on July 21, 2019. Place of performance is Bethesda, Maryland. The order covers laboratory supplies and consumables, priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. for $10,810.00 on August 18, 2020. The order covers biomedical reagents and research materials to be supplied from San Diego, California with a completion date of September 16, 2020. No set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $249,943.63 on September 16, 2019. The order covers DNA synthesis, plasmid, and protein production services. Work is performed in Piscataway, New Jersey. The purchase order is firm fixed price with an ultimate completion date of January 31, 2020. The order originated from a pre-solicitation opportunity posted September 11, 2019.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for DNA polymerase with a ceiling value of $35,250.56 on February 8, 2018, with ultimate completion on February 14, 2019. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for biomaterial on August 11, 2015, with a ceiling value of $34,000.00. Performance takes place in Grand Island, New York. The order is firm fixed price with an ultimate completion date of September 30, 2016.</p>